Cargando…
An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation
Mutations in CTNNB1, the gene encoding β-catenin, are common in colon and liver cancers, the most frequent mutation affecting Ser-45 in β-catenin. Peptides derived from WT β-catenin have previously been shown to be presented on the cell surface as part of major histocompatibility complex (MHC) class...
Autores principales: | Miller, Michelle S., Douglass, Jacqueline, Hwang, Michael S., Skora, Andrew D., Murphy, Michael, Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Zhou, Shibin, Gabelli, Sandra B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916501/ https://www.ncbi.nlm.nih.gov/pubmed/31690625 http://dx.doi.org/10.1074/jbc.RA119.010251 |
Ejemplares similares
-
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Hwang, Michael S., et al.
Publicado: (2021) -
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
por: Wright, Katharine M., et al.
Publicado: (2023) -
Targeting loss of heterozygosity for cancer-specific immunotherapy
por: Hwang, Michael S., et al.
Publicado: (2021) -
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
por: Kim, Kibem, et al.
Publicado: (2014) -
FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
por: Kinde, Isaac, et al.
Publicado: (2012)